Dube Eric Minsider trades
In SEC Form 4 filings, Dube Eric M is listed as CHIEF EXECUTIVE OFFICER of Travere Therapeutics, Inc. (TVTX). In the last 90 days, Dube Eric M sold $38.51M of Travere Therapeutics, Inc. (TVTX) on the open market and bought none. All 11 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | 21 | Oct 19 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-17
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | Oct 15 | Oct 19 | M | 43,735 | $26.88 | $1,175,597 | 476,621 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Oct 15 | Oct 19 | M | 200,000 | $8.93 | $1,786,000 | 676,621 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Oct 15 | Oct 19 | S | 128,065 | $52.97 | Sale −$6,783,244 | 548,556 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Oct 15 | Oct 19 | S | 37,270 | $54.20 | Sale −$2,020,023 | 511,286 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Oct 15 | Oct 19 | S | 78,400 | $55.02 | Sale −$4,313,403 | 432,886 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Oct 15 | Oct 19 | M · derivative | 43,735 | $26.88 | $1,175,597 | 168,925 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Oct 15 | Oct 19 | M · derivative | 200,000 | $8.93 | $1,786,000 | 160,000 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 17 | Sep 17 | M | 108,493 | $23.34 | $2,532,227 | 541,379 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 17 | Sep 17 | S | 101,691 | $64.59 | Sale −$6,567,876 | 439,688 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 17 | Sep 17 | S | 6,802 | $64.95 | Sale −$441,795 | 432,886 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 17 | Sep 17 | M · derivative | 108,493 | $23.34 | $2,532,227 | not reported | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | M | 195,841 | $23.34 | $4,570,929 | 628,727 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | S | 99,716 | $63.26 | Sale −$6,307,964 | 529,011 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | S | 96,125 | $63.64 | Sale −$6,117,289 | 432,886 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | M · derivative | 195,841 | $23.34 | $4,570,929 | 108,493 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M | 95,666 | $23.34 | $2,232,844 | 528,552 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 63,498 | $61.99 | Sale −$3,936,527 | 465,054 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 28,796 | $62.66 | Sale −$1,804,222 | 436,258 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 3,102 | $63.64 | Sale −$197,422 | 433,156 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 270 | $65.31 | Sale −$17,634 | 432,886 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 95,666 | $23.34 | $2,232,844 | 304,334 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.